
Cifibet100 mg
Eskayef Bangladesh Ltd.
Ciprofibrate is a fibric acid derivative (fibrate) indicated as an adjunct to diet and lifestyle modification for the management of the following conditions: Severe hypertriglyceridemia (established…
Ciprofibrate is a fibric acid derivative (fibrate) indicated as an adjunct to diet and lifestyle modification for the management of the following conditions:
Ciprofibrate is not indicated for the primary treatment of isolated hypercholesterolemia and should always be used alongside continued dietary and lifestyle management, not as a substitute for it.
| Indication | Recommended Dose |
|---|---|
| Hypertriglyceridemia / mixed dyslipidemia | 100 mg once daily, taken preferably with a meal (commonly recommended with the evening meal) |
Ciprofibrate is contraindicated in severe renal impairment. In mild-to-moderate renal impairment, dose reduction and close monitoring are required because Ciprofibrate is renally eliminated; consult a physician for individualized dosing.
Ciprofibrate is contraindicated in significant hepatic impairment, including primary biliary cirrhosis (see Contraindications).
Most patients tolerate Ciprofibrate well; however, the following adverse effects have been reported:
Ciprofibrate is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.